All In MedTech

FDA Clearance Tracker · P030011-S081

Total Artificial Heart

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 25, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 25, 2025

Approved

Time to decision

1,050 days

Received Aug 10, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030011-S081
Device name
Total Artificial Heart
Applicant location
Tucson, AZ
Received
Aug 10, 2022
Decided
Jun 25, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P030011

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code LOZ

FDA's approval statement

As written in FDA's record.

Approval for the protocol for the SynCardia 50cc temporary Total Artificial Heart (TAH-t) Post Approval Study.

Source documents

Other decisions for Syncardia Systems, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.